InvestorsHub Logo
icon url

fantomphan

03/18/20 2:02 PM

#20061 RE: biomed64 #20060

If $1000 is too much (it isn't IMO), then they'd think $500 is too. Not buying this price talk.
icon url

KCRoyal2004

03/18/20 2:06 PM

#20062 RE: biomed64 #20060

I agree that in these times, Cytosorbents should promote a "significantly reduced price for all of humanity" to get the world through this. Remember that we have 80% gross margins. Once people use, and if they deem effective (which has evidential support), word of mouth, and anecdotal evidence will drive Cytosorb volume. Secondarily, the company doesn't look bad from a p.r. perspective, either. Most importantly, lives will be saved as we have seen from study, after study, after study.

https://read.qxmd.com/search/paper/cytosorb%20cytokines
icon url

KCRoyal2004

03/18/20 2:06 PM

#20063 RE: biomed64 #20060

I agree that in these times, Cytosorbents should promote a "significantly reduced price for all of humanity" to get the world through this. Remember that we have 80% gross margins. Once people use, and if they deem effective (which has evidential support), word of mouth, and anecdotal evidence will drive Cytosorb volume. Secondarily, the company doesn't look bad from a p.r. perspective, either. Most importantly, lives will be saved as we have seen from study, after study, after study.

https://read.qxmd.com/search/paper/cytosorb%20cytokines